Precancerous lesions of the breast

Nature Clinical Practice Oncology

Volumn 5, Issue 12, 2008, Pages 700-704

  Costa, Alberto ^a   Zanini, Vittorio ^b  

^a EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^b IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TAMOXIFEN; VASCULOTROPIN;

BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST LOBULAR CARCINOMA; CANCER INVASION; CONSERVATIVE TREATMENT; ENDOSCOPY; ESTHETIC SURGERY; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECANCER; PRIORITY JOURNAL; REVIEW;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; PAPILLOMA; PRECANCEROUS CONDITIONS;

EID: 57049102844     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1239     Document Type: Review

References (32)

1. Sewell CW (2004) Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiol Clin North Am 42: 821-830
2. Jacobs TW et al. (2002) Nonmalignant lesions in breast core needle biopsies: To excise or not to excise? Am J Surg Pathol 26: 1095-1110
3. Morrow M (2004) The certainties and uncertainties of ductal carcinoma in situ. J Natl Cancer Inst 96: 424-425
4. Schreer I and Luttges J (2005) Precursor lesions of invasive breast cancer. Eur J Radiol 54: 62-71
5. Mulligan AM and O'Malley FP (2007) Papillary lesions of the breast: A review. Adv Anat Pathol 14: 108-119
6. Mercado CL et al. (2006) Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 238: 801-808
7. Krishnamurthy S and Sneige N (2002) Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9: 185-197
8. Stoll BA (1999) Premalignant breast lesions: Role for biological markers in predicting progression to cancer. Eur J Cancer 35: 693-697
9. Allred DC and Mohsin SK (2000) Biological features of human premalignant breast disease. In: Diseases of the Breast (Ed. Harris R) Philadelphia: Lippincott Williams & Wilkins
10. Veronesi U et al. (1998) Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study. Lancet 352: 93-97
11. Veronesi U et al. (2002) Tamoxifen for breast cancer among hysterectomised women. Lancet 359: 1122-1124
12. Veronesi U et al. (2007) Tamoxifen for the prevention of breast cancer: Late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst 99: 727-737
13. Lebeau A et al. (2003) EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 79: 187-198
14. Rudas M et al. (1997) p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular carcinoma in situ carcinomas of the breast. Eur J Cancer 33: 39-44
15. Rudland PS (1993) Epithelial stem cells and their possible role in the development of the normal and diseased breast. Histol Histopathol 8: 385-387
16. Viacava P et al. (2004) Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol 204: 140-146
17. Viacava P et al. (2004) Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol 204: 140-146
18. Hyder SM (2006) Sex-steroid regulation of vascular endothelial growth factor in breast cancer. Endocr Relat Cancer 13: 667-687
19. Viacava P et al. (1999) Different proliferative patterns characterize different preinvasive breast lesions. J Pathol 188 245-251
20. Mustonen M et al. (1997) The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions. Histopathology 31: 347-354
21. Liberman L (2002) Percutaneous image-guided core breast biopsy. Radiol Clin North Am 40: 483-500
22. Liberman L et al. (2007) Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 188: 684-690
23. Ernster VL et al. (2000) Mortality among women with ductal carcinoma in situ of the breast in the population based Surveillance, Epidemiology and End Results Program. Arch Intern Med 160: 953-958
24. Ernster VL et al. (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94 1546-1554
25. Intra M et al. (2007) Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): The experience of the European Institute of Oncology. Eur J Nucl Med Mol Imaging 34: 957-958
26. Baxter NN et al. (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96 443-448
27. Fisher B et al. (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328: 1581-1586
28. Houghton J et al. (2003) UK Coordinating Committee on Cancer Research; Ductal carcinoma in situ working party; DCIS trialists in the UK, Australia and New Zealand: Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ: Randomized controlled clinical trial. Lancet 362: 95-102
29. Association of Breast Surgery at BASO, BAPRAS and the Training Interface Group in Breast Surgery et al. (2007) Oncoplastic breast surgery - a guide to good practice. Eur J Surg Oncol 33 (suppl 1): S1-S23
30. Silverstein MJ et al. (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77: 2267-2274
31. Morrow M et al. (2000) DCIS and microinvasive carcinoma. In Diseases of the Breast. (Ed. Harris JR) Philadelphia: Lippincott Williams & Wilkins
32. Silverstein MJ et al. (1997) Breast irradiation is unnecessary for widely excised DCIS. Breast Cancer Res Treat 46: 23